ONCY P/E Ratio
P/E Ratio as of Jun 13, 2025: -2.10
Average-1.45
Median-1.42
Minimum-2.10
Maximum-1.15
-2.10
Past Month-0.37 (21.39%)
The P/E ratio for ONCY is -2.10 as of Jun 13, 2025. This represents a decrease of -26.83% compared to its 12-month average P/E ratio of -2.87. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Oncolytics Biotech, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Oncolytics Biotech, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Oncolytics Biotech, Inc. to industry peers.
Oncolytics Biotech, Inc. P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Oncolytics Biotech, Inc.’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Oncolytics Biotech, Inc. to industry peers.
ONCY P/E Ratio Insights
See Oncolytics Biotech, Inc.’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in ONCY
Order type
Buy in
Order amount
Est. shares
0 shares
ONCY P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Jun 2, 2025 | $0.344 | -1.19 |
| May 1, 2025 | $0.55 | -1.82 |
| Apr 1, 2025 | $0.527 | -1.74 |
| Mar 3, 2025 | $0.663 | -2.48 |
| Feb 3, 2025 | $0.6945 | -2.59 |
| Jan 2, 2025 | $0.9298 | -3.47 |
ONCY End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -2.10 | -38.42% |
| 2024 | -3.41 | -5.54% |
| 2023 | -3.61 | -26.18% |
| 2022 | -4.89 | +38.14% |
| 2021 | -3.54 | -40.50% |
| 2020 | -5.95 | — |
FAQs About Oncolytics Biotech, Inc. (ONCY) P/E ratio
The latest P/E ratio of ONCY is -2.10, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Oncolytics Biotech, Inc.’s last 12-month average P/E ratio is -2.87, compared to its current P/E ratio of -2.10. This reflects a decrease of -26.83%.
Oncolytics Biotech, Inc.’s current P/E ratio of -2.10 is lower than its last 12-month average P/E of -2.87. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Oncolytics Biotech, Inc.’s average P/E ratio over the last 3 years is -4.13. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Oncolytics Biotech, Inc.’s average P/E ratio over the last 5 years is -4.28. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.